Episode 52: Why Is Neuroendocrine Cancer on the Rise?

Neuroendocrine cancer diagnoses have increased dramatically over the past several decades—but are these cancers actually becoming more common, or are we simply getting better at detecting them? In this episode of NETWise, leading clinicians, researchers, and a patient explore what’s driving the rise in neuroendocrine cancer diagnoses and what it means for patients today. From advances in imaging and pathology to the growing number of tumors discovered incidentally, this conversation reveals how earlier detection is reshaping care, research, and outcomes. In this episode, you’ll learn: • Why neuroendocrine cancer diagnoses have increased so significantly • How modern imaging and improved diagnostics are helping identify tumors earlier • Why many tumors are now found before symptoms appear • The environmental, biological, and social factors researchers are still working to understand • How earlier detection is creating new opportunities—and new challenges—for treatment decisions • A patient’s personal story and how awareness can lead to earlier answers As science advances, so does our ability to detect and treat neuroendocrine cancer with greater precision. This episode brings clarity to the rising numbers and what that progress means for patients, caregivers, and clinicians. Whether you’re a patient, caregiver, clinician, or advocate, this episode offers clear, accessible insights into the breakthroughs driving research forward.. Please like, share, and subscribe. Your engagement helps us reach more patients and caregivers seeking reliable neuroendocrine cancer information—and supports NETRF’s mission to expand research, awareness, and hope across the neuroendocrine cancer community. • To download a copy of the transcript for this episode: https://netrf.org/wp-content/uploads/... • To listen to other NETWise episodes: https://netrf.org/podcast/ NETWise is a podcast featuring neuroendocrine cancer experts and patient perspectives, produced by the Neuroendocrine Tumor Research Foundation (NETRF) in Quincy, MA, USA. • Episode 52: Why Is Neuroendocrine Cancer on the Rise? • Neuroendocrine Tumor Research Foundation (NETRF)